Title
Category
Credits
Event date
Cost
  • Delivery of Care
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
What diagnostic criteria and assessment tools would you use for dementia-related psychosis? What strategies may help when discussing psychosis with patients’ family members? Dr Ballard considers these topics in this brief CME activity.
  • Alzheimer Disease
  • Cognition
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Primary Care
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Learn from experts in neurology, psychiatry, neuropsychology, and primary care about working with patients and care partners to create management plans for Alzheimer’s disease that ensure safety, optimize patient autonomy, and minimize agitation and conflict.
  • Alzheimer Disease
  • Cognition
  • Delivery of Care
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Patient/Physician Communication
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
In a series of brief video segments, experts in neurology, psychiatry, and primary care discuss the diagnosis and treatment of Alzheimer’s disease.
  • Depression
  • Electroconvulsive Therapy
  • Geriatric Psychiatry
  • Psychotherapy
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
How many older adults receive electroconvulsive therapy (ECT) for treatment-resistant depression? Among those who receive ECT, how many finish the course? What factors might predict patients’ continuation of ECT? Explore these topics in this journal CME activity.
  • Dementia
  • Diagnostic Tools
  • Geriatric Psychiatry
  • Neurology
  • Neuropsychiatric Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
InstructionsClick the red REGISTER button to pay the $10 fee and take the posttest. Click here to return to the JCP CME article
  • Alzheimer Disease
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Psychotic Disorders
  • Violence/Aggression
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
When you treat patients with dementia-related psychosis, do you evaluate the burden on carers, too? If they feel discomfort, fear, or depression, how would you help them? Learn from an expert in this brief CME activity.
  • Geriatric Psychiatry
  • Pain
  • Substance Use Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
How does prescription opioid misuse affect people who are 50 years old and older? What factors should clinicians look for when screening? Review this CME.
  • Antidepressants
  • Depression
  • Geriatric Psychiatry
  • Journal of Clinical Psychiatry
  • AMA PRA Category 1 Credit™
  • Participation
$10.00
Rates of treatment resistance in randomized controlled trials in patients with late-life depression are as high as 77% using SSRIs, yet SSRIs are often used as first-line treatment. This CME article helps to optimize the selection of the next step in treating late-life depression.
  • Dementia
  • Geriatric Psychiatry
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Dementia-related psychosis (DRP) occurs in all forms of dementia and at all stages. What tactics should be used when talking with patients and their care partners about DRP? How is it best treated?
  • Alzheimer Disease
  • Antipsychotics
  • Dementia
  • Geriatric Psychiatry
  • Neurology
  • Parkinson Disease
  • Psychotic Disorders
  • AMA PRA Category 1 Credit™
  • Participation
$0.00
Antipsychotics can be used in the short-term to manage dementia-related psychosis, but serious adverse effects can outweigh benefits. Novel antipsychotics or other agents may offer superior efficacy and safety. Explore the evidence in this CME activity.

Pages